Sendero Wealth Management LLC cut its holdings in Genpact Limited (NYSE:G - Free Report) by 42.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,710 shares of the business services provider's stock after selling 10,145 shares during the period. Sendero Wealth Management LLC's holdings in Genpact were worth $603,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in G. Envestnet Portfolio Solutions Inc. lifted its stake in shares of Genpact by 59.2% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock valued at $522,000 after purchasing an additional 3,849 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in Genpact by 20.6% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock worth $486,000 after buying an additional 1,651 shares during the period. Wright Investors Service Inc. bought a new position in Genpact during the second quarter valued at $457,000. GAMMA Investing LLC raised its stake in shares of Genpact by 88.0% in the first quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock valued at $491,000 after acquiring an additional 4,561 shares during the period. Finally, Assenagon Asset Management S.A. bought a new stake in shares of Genpact in the 1st quarter worth about $2,396,000. Institutional investors own 96.03% of the company's stock.
Genpact Stock Performance
Shares of G stock opened at $41.23 on Monday. The firm has a market cap of $7.19 billion, a price-to-earnings ratio of 13.70, a PEG ratio of 1.41 and a beta of 0.89. Genpact Limited has a 52-week low of $37.82 and a 52-week high of $56.76. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. The company's 50 day moving average is $43.36 and its 200 day moving average is $44.86.
Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.03. The business had revenue of $1.25 billion for the quarter, compared to analysts' expectations of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The business's revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, sell-side analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th were issued a $0.17 dividend. The ex-dividend date was Thursday, September 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.6%. Genpact's payout ratio is currently 22.59%.
Analyst Ratings Changes
Several equities analysts recently commented on G shares. Needham & Company LLC upped their price target on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a report on Friday, August 8th. Deutsche Bank Aktiengesellschaft began coverage on Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 target price on the stock. Wall Street Zen lowered Genpact from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Mizuho upped their price objective on Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research report on Tuesday, July 1st. Finally, JPMorgan Chase & Co. reduced their target price on Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 20th. Three analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $52.29.
Check Out Our Latest Stock Report on Genpact
Insider Activity
In related news, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the sale, the chief executive officer owned 295,246 shares of the company's stock, valued at $12,801,866.56. This represents a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Piyush Mehta sold 76,902 shares of the firm's stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the completion of the sale, the senior vice president owned 134,880 shares of the company's stock, valued at approximately $5,743,190.40. This trade represents a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company's stock.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report